Arbutus Biopharma Corp (ABUS)
2.98
+0.09
(+3.11%)
USD |
NASDAQ |
May 17, 16:00
2.985
0.00 (0.00%)
After-Hours: 20:00
Arbutus Biopharma Stock Buybacks (Quarterly): -21.76M for March 31, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -21.76M |
| December 31, 2023 | -3.852M |
| September 30, 2023 | -1.396M |
| June 30, 2023 | -4.742M |
| March 31, 2023 | -19.86M |
| December 31, 2022 | -11.08M |
| September 30, 2022 | -8.973M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -0.268M |
| December 31, 2021 | -59.24M |
| September 30, 2021 | -44.74M |
| June 30, 2021 | -4.274M |
| March 31, 2021 | -26.42M |
| December 31, 2020 | -20.18M |
| September 30, 2020 | -48.76M |
| June 30, 2020 | -5.045M |
| March 31, 2020 | -12.32M |
| December 31, 2019 | -13.88M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | -2.477M |
| March 31, 2019 | -2.248M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 |
| Date | Value |
|---|---|
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 0.00 |
| September 30, 2016 | |
| June 30, 2016 | 0.00 |
| March 31, 2016 | |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | -0.002M |
| March 31, 2015 | -142.18M |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | -56.48M |
| December 31, 2013 | -32.04M |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.059M |
| September 30, 2012 | -0.1261M |
| June 30, 2012 | 0.0734M |
| March 31, 2012 | -3.850M |
| December 31, 2011 | -0.2082M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-59.24M
Minimum
Dec 2021
--
Maximum
Sep 2019
-15.46M
Average
-10.03M
Median
Stock Buybacks (Quarterly) Benchmarks
| Moderna Inc | 0.00 |
| Pfizer Inc | -- |
| Regeneron Pharmaceuticals Inc | -47.10M |
| Chimerix Inc | -- |
| Karyopharm Therapeutics Inc | -- |